More articles from Study protocols

The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma
Pepa Bruce, Lee Hatter, Claire Houghton, Ciléin Kearns, Mark Holliday, Augustus J. Anderson, Allie Eathorne, John Martindale, Alex Semprini, Mark Weatherall, Ian Pavord, Tim Harrison, Alberto Papi, Rob Horne, Richard Beasley

ERJ Open Research Sep 2023, 9 (5) 00239-2023; DOI: 10.1183/23120541.00239-2023
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
Kathryn Date, Bronwen Williams, Judith Cohen, Nazia Chaudhuri, Sabrina Bajwah, Mark Pearson, Irene Higginson, John Norrie, Catriona Keerie, Sharon Tuck, Peter Hall, David Currow, Marie Fallon, Miriam Johnson

ERJ Open Research Jul 2023, 9 (4) 00167-2023; DOI: 10.1183/23120541.00167-2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
James D. Chalmers, Abhya Gupta, Sanjay H. Chotirmall, April Armstrong, Peter Eickholz, Naoki Hasegawa, Pamela J. McShane, Anne E. O'Donnell, Michal Shteinberg, Henrik Watz, Anastasia Eleftheraki, Claudia Diefenbach, Wiebke Sauter

ERJ Open Research May 2023, 9 (3) 00633-2022; DOI: 10.1183/23120541.00633-2022
The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis
Els van der Heijden, Rutger M. van den Bor, Cornelis K. van der Ent, Sanne L. Nijhof, Sabine E.I. van der Laan

ERJ Open Research May 2023, 9 (3) 00535-2022; DOI: 10.1183/23120541.00535-2022
The national COPD screening programme in China: rationale and design
Jieping Lei, Ke Huang, Jun Pan, Wei Li, Hongtao Niu, Xiaoxia Ren, Fen Dong, Yong Li, Baicun Li, Cunbo Jia, Ting Yang, Chen Wang

ERJ Open Research Mar 2023, 9 (2) 00597-2022; DOI: 10.1183/23120541.00597-2022
Precision Medicine Intervention in Severe Asthma (PRISM) study: molecular phenotyping of patients with severe asthma and response to biologics
Ji-Hyang Lee, Piers Dixey, Pank Bhavsar, Katie Raby, Nazanin Kermani, Marc Chadeau-Hyam, Ian M. Adcock, Woo-Jung Song, Hyouk-Soo Kwon, Sei-Won Lee, You Sook Cho, Kian Fan Chung, Tae-Bum Kim

ERJ Open Research Mar 2023, 9 (2) 00485-2022; DOI: 10.1183/23120541.00485-2022
Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy
Helen Marshall, Jim M. Wild, Laurie J. Smith, Latife Hardaker, Titti Fihn-Wikander, Hana Müllerová, Rod Hughes

ERJ Open Research Mar 2023, 9 (2) 00344-2022; DOI: 10.1183/23120541.00344-2022
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β₂-agonist therapy in patients with asthma: REACH study design
Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami, Norihiko Kondo

ERJ Open Research Mar 2023, 9 (2) 00452-2022; DOI: 10.1183/23120541.00452-2022
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
Lucia De Prado Gomez, Ian Pavord, William Busse, Christopher E. Brightling, Michael E. Wechsler, Klaus F. Rabe, Mei Zhang, Jun Xing, Juby A. Jacob-Nara, Paul J. Rowe

ERJ Open Research Mar 2023, 9 (2) 00417-2022; DOI: 10.1183/23120541.00417-2022
Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial
Fiona Cunningham, Ellen Caldwell, Nicole Mayer-Hamblett, Christopher H. Goss, Marianne S. Muhlebach

ERJ Open Research Oct 2022, 8 (4) 00190-2022; DOI: 10.1183/23120541.00190-2022

Main menu

User menu

Search

More articles from Study protocols

Pages

Contact us